Immunologic basis of chronic allergic diseases: Clinical messages from the laboratory bench

Pediatric Research

Volumn 42, Issue 5, 1997, Pages 559-568

  Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC DISEASE; CHRONIC DISEASE; EOSINOPHIL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOPATHOGENESIS; MAST CELL; MEMORY CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 0030777791     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199711000-00001     Document Type: Review

References (115)

1. Schultz-Larsen F, Diepgen T, Svensson A 1996 The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol 34:760-764
2. Centers for Disease Control and Prevention 1996 Asthma mortality and hospitalization among children and young adults - United States, 1990-1993. MMWR 45:350-353
3. Leung DYM 1994 Mechanisms of the human allergic response: clinical implications. Pediatr Clin North Am 41:727-743
4. Mudde GC, Van Reijsen FC, Boland GJ, DeGast GC, Bruijnzeel PLB, Bruijnzeel-Koomen CAFM 1990 Allergen presentation by epidermal Langerhans cells from patients with atopic dermatitis is mediated by IgE. Immunology 69:335-341
5. Leung DYM 1993 Role of IgE in atopic dermatitis. Curr Opin Immunol 5:956-962
6. Dolovich J, Hargreave FE, Chalmers R, Shier KJ, Gauldie J, Bienenstock J 1973 Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 52:38-46
7. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM 1989 Cutaneous late-phase response to allergen: Mediator release and inflammatory cell infiltration. J Clin Invest 83:1519-1526
8. Kay AM, Ying S, Varney V, Gaga, M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q 1991 Messenger RNA expression of cytokine gene cluster, interleukin 3 (IL-3), IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173:775-778
9. Cartier A, Thomson N, Frith P, Roberts R, Hargreave FE 1982 Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 70:170-177
10. Warner J, Price J, Soothill J, Hey E 1978 Controlled trial of hyposensitization with Dermatophagoides pteronyssinus antigen in children with asthma. Lancet 2:912-917
11. Kay AB 1991 Asthma and Inflammation. J Allergy Clin Immunol 87:893-913
12. Leung DYM (ed) 1996 Atopic Dermatitis: From Pathogenesis to Treatment. R. G. Landes Co., Austin, TX, pp 1-226
13. Sur S, Crotty TB, Kephart GM 1993 Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 148:713-719
14. Wenzel SE, Szefler SJ, Leung DYM, Sloan SI, Rex MD, Martin RJ 1997 Bronchoscopic evaluation of severe asthma: persistent inflammation despite high dose glucocorticoids. Am J Respir Crit Care Med (in press)
15. Weller P 1992 Cytokine regulation of eosinophil function. Clin Immunol Immunopathol 62:55-59
16. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326:298-304
17. Hamid Q, Boguniewicz M, Leung DYM 1994 Differential cytokine gene expression in acute vs chronic atopic dermatitis. J Clin Invest 94:870-876
18. Bochner BS, Schleimer RP 1994 The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 94:427-438
19. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RR 1991 Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule-1 and endothelial leukocyte adhesion molecule-1. Proc Natl Acad Sci USA 88:7430-7433
20. Baggiolini M, Dahinden CA 1994 CC chemokines in allergic inflammation. Immunol Today 15:127-133
21. Smith C, Barker J, Lee T 1993 Adhesion molecules in allergic inflammation. Am Rev Respir Dis 148:S 75:78
22. Montefort S, Roche WR, Howart PH, Djukanovic R, Gratziou C, Carroll M, Smith L, Britten KM, Haskard D, Lee TH, Holgate ST 1992 Intercellular adhesion molecule-1 (ICAM-1) and endothelial leukocyte adhesion molecule-1. Eur Respir J 5:815-823
23. Groves RW, Allen MH, Haskard DO, MacDonald DM 1991 Endothelial leukocyte adhesion molecule-1 in acute and chronic eczema. In: Czernielewski JM (ed) Immunological and Pharmacological Aspects of Atopic and Contact Eczema. Karger, Basel, pp 85-88
24. Kyan-Aung U, Haskard D, Poston R, Thornhill MH, Lee TH 1991 Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cell in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 146:521-528
25. Leung D, Pober J, Cotran R 1991 Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 87:1805-1809
26. Bittleman D, Casale T 1994 Allergic models and cytokines. Am J Respir Crit Care Med 150:572-76
27. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP 1995 IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J immunol 154:799-803
28. Walsh G, Mermod J, Harnell A, Kay AB, Wardlaw AJ 1991 Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is α4α1 (very late antigen-4) dependent. J Immunol 146:3419-3423
29. Stellato C, Collins P, Ponath PD, Soler D, Newman W, La Rosa G, Haodong L, White J, Schwiebert LM, Bickel C, Liu M, Bochner BS, Williams T, Schleimer RP 1997 Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines. J Clin Invest 99:926-936
30. Heath H, Shixin Q, Rao P, Wu L, LaRosa G, Kassam N, Ponath PD, Mackay CR 1997 Chemokine receptor usage by human eosinophils. J Clin Invest 99:178-184
31. + T cells. Annu Rev Immunol 12:635-673
32. + T cell clones. J Exp Med 173:747-750
33. de Vries J 1994 Novel fundamental approaches to intervening in IgE-mediated allergic diseases. J Invest Dermatol 102:141-144
34. Jujo K, Renz H, Abe J, Gelfand EW, Leung DYM 1992 Decreased gamma Interferon and increased interleukin-4 production promote IgE synthesis in atopic dermatitis. J Allergy Clin Immunol 90:323-330
35. Renz H, Jujo K, Bradley, KL, Domenico J, Gelfand EW, Leung DYM 1992 Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by Interferon-γ. J Invest Dermatol 99:403-408
36. H2 murine helper T lymphocyte clones using IL-2 and recombinant IFN-γ. J Immunol 143:15-22
37. H2 cells. Int Arch Allergy Immunol 113:153-156
38. H2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 23:1445-1449
39. H2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 90:184-92
40. Naseer T, Minshall EM, Laberge S, Ernst P, Martin RJ, Leung DYM, Hamid Q 1997 Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 155:845-851
41. Hamid Q, Naseer T, Minshall EM, Song TL, Boguniewicz M, Leung DYM 1996 In vivo expression of interleukin-12 and interleukin-13 in atopic dermatitis. J Allergy Clin Immunol 98:225-231
42. H2 cells. J Immunol 148:3820-3829
43. H1 ) specific immune responses and inhibits the development of IL-4 producing T cells. J Exp Med 177:1199-1204
44. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F 1997 Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185:825-831
45. Seaton A, Godden DJ, Brown K 1994 Increase in asthma: a more toxic environment or a more susceptible population? Thorax 49:171-174
46. Shirakawa T, Enomoto T, Shimazu S-I, Hopkin JM 1997 The inverse association between tuberculin responses and atopic disorder. Science 275:77-79
47. Leung DYM, Picker LJ 1997 Adhesion pathways controlling recruitment responses of lymphocytes during allergic inflammatory reactions in vivo. In: Bochner BS (ed) Adhesion Molecules in Allergic Disease. Marcel Dekker, New York, pp 297-314
48. Butcher EC, Picker LJ 1996 Lymphocyte homing and homeostasis. Science 272:60-66
49. Picker LJ, Martin RJ, Trumble A, Newman L, Collins PA, Bergstresser PR, Leung DYM 1994 Control of lymphocyte recirculation in man: differential expression of homing-associated adhesion molecules by memory/effector T cells in pulmonary vs cutaneous effector sites. Eur J Immunol 24:1269-1277
50. Abemathy-Carver KJ, Sampson HA, Picker LJ, Leung DYM 1995 Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 95:913-918
51. Santamaria Babi LF, Picker LJ, Perez Soler MT, Drzimalla K, Flohr P, Blaser K, Hauser C 1995 Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 181:1935-1940
52. Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ 1995 Bacterial superantigens induce T cell expression of the skin-selective homing receptor the cutaneous lymphocyte-associated (CLA) antigen via stimulation of IL-12 production. J Exp Med 181:747-753
53. Leung DYM, Harbeck H, Bina P, Reiser RF, Yang E, Norris AD, Hanifin JM, Sampson HA 1993 Presence of IgE antibodies to staphylococcal enterotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 92:1374-80
54. Jones SM, Sampson HA 1996 The role of allergens in atopic dermatitis. In: Leung DYM (ed) Atopic Dermatitis: From Pathogenesis to Treatment. R. G. Landes Co, Austin, TX, pp 41-66
55. Chan SC, Kim JW, Henderson Jr WR, Hanifin JM 1993 Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 151:3345-3352
56. Lester MR, Gately M, Trumble A, Leung DYM 1995 Effects of IL-12 and staphylococcal toxic shock syndrome toxin-1 on the interferon-γ response in atopic dermatitis. J Immunol 95:913-918
57. Matsumoto K, Schleimer RP, Saito H, Likura Y, Bochner BS 1995 Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 86:1437-1443
58. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ 1995 Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291
59. Enari M, Hug H, Nagata S 1995 Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375:78-81
60. Suzuki S, Okubo M, Kaise S, Ohara M, Kasukawa R 1995 Gold sodium thiomalate selectivity inhibits interleukin-5-mediated eosinophil survival. J Allergy Clin Immunol 96:251-256
61. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. 1995 Granulocyte macrophage-colony stimulating factor inhibition of monocyte apoptosis contributes to the chronic monocyte activation in atopic dermatitis. J Clin Invest 95:211-218
62. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ 1996 Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 154:237-243
63. Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DYM 1997 Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Cell Mol Biol 155:87-93
64. Clayton MH, Leung DYM, Surs W, Szefler SJ 1995 Altered glucocorticoid receptor binding in atopic dermatitis. J Allergy Clin Immunol 96:421-423
65. Herrscher RF, Kasper C, Sullivan TJ 1992 Endogenous cortisol regulates immunoglobulin E-dependent late phase reaction. J Clin Invest 90:596-603
66. Duffy DL, Martin NG, Battistutta D, Hopper JL, Mathews JD 1990 Genetics of asthma and hay fever in Australian twins. Am Rev Respir Dis 142:1351-1358
67. Holgate ST 1997 Asthma genetics: waiting to exhale. Nat Genet 15:227-229
68. Moffatt MF, Hill MR, Cornelis F, Schou C, Faux JA, Young RP, James AL, Ryan G, le Souef P, Musk AW 1994 Genetic linkage of T cell receptor αlδ complex to specific IgE responses. Lancet 343:1597-1600
69. Marsh DG, Neely JD, Breazeale R, Ghosh B, Friedhoff LR, Schou C, Beaty TH 1995 Total serum IgE levels and chromosome 5q. Clin Exp Allergy 25(suppl 2):79-83
70. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH 1994 Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum IgE concentrations. Science 264:1152-1156
71. Postma DS, Bleecker ER, Amelung PJ, Holroyd KJ, Xu J, Panhuysen CI, Meyers DA, Levitt RC 1995 Genetic suscetpibility to asthma-bronchial hyperresponsivness coinherited with a major gene for atopy. N Engl J Med 333:894-900
72. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, Klinnert M, Borish L 1995 Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 25:74-78
73. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8:334-339
74. 16 correlates with the nocturnal phenotype. J Clin Invest 95:1635-1641
75. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213-1214
76. Walker KB, Potter JM, House AK 1987 Interleukin 2 synthesis in the presence of steroid: a model of steroid resistance. Clin Exp Immunol 68:162-167
77. Leung DYM 1995 The glucocorticoid receptor as a target in the pathogenesis of steroid resistant asthma. In: Szefler SJ, Leung DYM (eds) Severe Asthma: Pathogenesis and Management. Marcel Dekker, New York, pp 285-312
78. Lee TH, Brattsand R, Leung DYM (eds) 1996 Corticosteroid action and resistance in asthma. Am J Respir Cell Mol Biol 154(suppl):S1-S79
79. Moore BB, Weiss KB, Sullivan SD 1995 Epidemiology and Socioeconomic Impact of Severe Asthma. In: Szefler SJ, Leung DYM (eds) Severe Asthma: Pathogenesis and Management. Marcel Dekker, New York, pp 285-312
80. Alvarez J, Surs W, Leung DYM, Iklé D, Gelfand EW, Szefler SJ 1992 Steroid-resistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 89:714-721
81. Corrigan CJ, Brown PH, Barnes NC, Tsai J.-J, Frew AJ, and Kay AB 1991 Glucocorticoid resistance in chronic asthma. Am Rev Respir Dis 144:1026-1032
82. Munck A, Mendel DB, Smith LI, Orti E 1990 Glucocorticoid receptors and actions. Am Rev Respir Dis 141:S2-S10
83. Sher ER, Leung DYM, Surs W, Kam JC, Zieg G, Kamada AK, Harbeck R, Szefler SJ 1994 Steroid resistant asthma: cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93:33-39
84. Kam J, Szefler SJ, Surs W, Sher E, Leung DYM 1993 The combined effects of IL-2 and IL-4 alter the binding affinity of the glucocorticoid receptor. J Immunol 151:3460-3466
85. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Ying S, Ming Q, Kay AB, Hamid Q 1995 The airways of steroid resistant vs. steroid sensitive asthma are associated with different patterns of cytokine gene expression. J Exp Med 181:33-40
86. Bamberger, CM, Bamberger AM, de Castro M, and Chrousos, GP 1995. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-2441
87. Leung DYM, Wenzel S, Szefler SJ, Spahn JD, Surs W, Chrousos GP, Hamid Q 1997 Association of steroid resistant (SR) asthma with increased numbers of cells expressing glucocorticoid receptor (GR) β. J Allergy Clin Immunol 99:S496(abstr)
88. Sears MR, Herbison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA 1989 The relative risk of sensitivity to grass pollen, house dust mite and cat dander in the development of childhood asthma. Clin Exp Allergy 19:419-424
89. Schwartz J, Slater D, Larson T, Pierson W, Koenig J 1993 Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 147:826-831
90. Haahtela T, Jarvinen M, Kava T 1994 Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700-705
91. Agertoft L, Pedersen S 1994 Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88:373-381
92. Spahn JD, Leung DYM, Szefler SJ 1996 Difficult to control asthma: new insights and implications for management. In: Szefler SJ, Leung DYM (eds) Severe Asthma: Pathogenesis and Management. Marcel Dekker, New York, pp 497-536
93. + T cells from allergic individuals. J Exp Med 178:2123-2130
94. Schleimer RP, Beck L, Schwiebert L, Stellato C, Davenpeck K, Bochner BS 1997 Inhibition of inflammatory cell recruitment by glucoconicoids: cytokines as primary targets. In: Schleimer RP, Busse WW, O'Byrne P (eds) Topical Glucoconicoids in Asthma: Mechanisms and Clinical Actions. Marcel Dekker, New York, pp 203-238
95. Corne J, Djukanovic R, Thomas L, Wamer J, Botta L, Grandordy B, Gygax D, Heusser C, Patalano F, Richardson W, Kilchherr E, Staehelin T, Davis F, Gordon W, Sun L, Liou R, Wang G, Chang TW, Holgate S 1997 The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J Clin Invest 99:879-887
96. Campbell DA, Field M, McArdle CS, Cooke TG, Gallagher G 1994 Polymorphism at the tumour necrosis factor locus: a marker of genetic predisposition to colorectal cancer? [letter] Lancet 343:293-294
97. Shirakawa T, Li A, Dubowitz M, Dekker JW, Shaw AE, Faux JA, Ra C, Cookson WO, Hopkin JM 1994 Association between atopy and variants of the β subunit of the high affinity immunoglobulin E receptor. Nat Genet 7:125-129
98. Barnes KC, Neely JD, Duffy DL, Freidhoff LR, Breazeale DR, Schou C, Naidu RP, Levett PN, Renault B, Kucherlapati R, Iozzino S, Ehrlich E, Beaty TH, Marsh DG 1996 Linkage of asthma and total serum IgE concentration to markers on chromosome 12q: evidence from Afro-Caribbean and Caucasian populations. Genomics 37:41-50
99. Mazer BD, Gelfand EW 1991 An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 87:976-983
100. Leung DYM, Burns J, Newburger J, Geha RS 1987 Reversal of immunoregulatory abnormalities in Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest 79:468-472
101. Alexander AG, Barnes NC, Kay AB 1992 Trial of cyclosporin A in corticosteroid-dependent chronic severe asthma. Lancet 339:324-328
102. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Allen BR, Camp RD 1991 Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137-140
103. Mori A, Suko M, Nishizaki Y, Kaminuma O, Matsuzaki G, Ito K, Etoh T, Nakagawa H, Tsuruoka N, Okudaira H 1994 Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int Arch Allergy Immunol 104:32-35
104. Boguniewicz M, Leung DYM, Fiedler V, Lawrence I, Hanifin J, Tacrolimus Study Group 1997 Treatment of pediatric atopic dermatitis (AD) with tacrolimus ointment. J Allergy Clin Immunol 99(part 2):1939(abstr)
105. Norman PS 1993 Modern concepts of immunotherapy. Curr Opin Immunol 5:968-973
106. Van Oosterhout AJ, Ladenius AR, Savelkoul HF, Van Ark I, Delsman KC, Nijkamp FP 1993 Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 147:548-552
107. Bum SY, Haile S, Lefort J, Huerre M, Vargaftig BB 1995 Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA 92:12290-12294
108. Renz H, Enssle K, Laulfer L, Kurrle R, Gelfand EW 1995 Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int Arch Allergy Immunol 106:46-54
109. Sim T, Hilsmeier K, Reece L, Grant JA, Alam R 1994 Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am J Respir Cell Mol Biol 11:473-447
110. Hanifin JM, Schneider LC, Leung DY, Ellis CN, Jaffe HS, Izu AE, Bucalo LR, Hirabayashi SE, Tofte SJ, Cantu-Gonzales G 1993 Recombinant Interferon γ therapy for atopic dermatitis. J Am Acad Dermatol 28:189-197
111. Boguniewicz M, Jafle HS, Izu A, Sullivan MJ, York D, Geha RS, Leung DYM 1990 Recombinant γ Interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 88:365-370
112. Boguniewicz M, Martin RJ, Martin D, Gibson U, Celniker A, Williams M, Leung DYM 1995 The effects of nebulized recombinant interferon γ in asthmatic airways. J Allergy Clin Immunol 95:133-135
113. Paukkonen K, Fraki J, Horsmanheimo M 1993 Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis. Acta Dermato-Venereol 73:141-142
114. Gruschwitz MS, Peters KP, Heese A, Stosiek N, Koch HU, Hornstein OP 1993 Effects of interferon-α-2b on the clinical course, inflammatory skin infiltrates and peripheral blood lymphocytes in patients with severe atopic eczema. Int Arch Allergy Immunol 101:20-30
115. H2 cytokine expression in mice. J Exp Med 182:1527-1536